Associated Papers
The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS.
Bansod S et al.
Cell Reports, 2024
RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations.
Bonsor DA et al.
Annual Review of Cancer Biology, 2024
Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS.
Tanaka T et al.
The Embo Journal, 2007
Expression of ral GTPases, their effectors, and activators in human bladder cancer.
Smith SC et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2007
Select a paper to view details